Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
Eikon plans IPO to bankroll clutch of clinical cancer drugs
Eikon is planning to become the second biotech to go public in 2026 in another sign the public markets are looking attractive to drug developers.
James Waldron
Jan 12, 2026 4:40am
Radiopharma-focused Aktis bring in $318M via upsized IPO
Jan 9, 2026 4:52am
Aktis aims for $209M windfall from 1st biotech IPO of 2026
Jan 5, 2026 9:30am
Big Pharma-backed Aktis plans IPO to fund radiopharma trials
Dec 22, 2025 8:55am
Lumexa Imaging IPO tallies $462.5M, doubling original target
Dec 15, 2025 9:40am
Global uncertainties can't dampen upbeat Jefferies conference
Nov 24, 2025 3:00am
